Riken
Amoy Diagnostics CDx Gets Japanese Approval to ID NSCLC Patients Eligible for Tepmetko
The Japanese Ministry of Health, Labor, and Welfare has approved AmoyDx's PLC Panel for use in identifying NSCLC patients with MET exon 14 skipping alterations.
AmoyDx PCR Panel Receives Japanese Approval as CDx for Non-Small Cell Lung Cancer Therapies
The Japanese MHLW approved the real-time PCR-based test as a CDx to detect four driver genes for nine associated NSCLC targeted therapies.
Coronary Artery Disease Loci Identified in Japanese GWAS, Trans-Ancestry Meta-Analysis
Researchers found ancestry-specific risk variants and developed a better polygenic risk score based on a GWAS and subsequent meta-analysis.
Large-Scale Japanese GWAS Uncovers Two Novel Loci Associated With Lung Cancer, Heart Disease
The GWAS of more than 200,000 Japanese individuals across 42 diseases identified 25 novel loci shared between Japanese and European populations.
Both studies emerged from the ongoing Human Cell Atlas project and could help scientists decide on the best approaches to use in various contexts.
Oct 23, 2017
Apr 17, 2017
New Variants Linked to Atrial Fibrillation Risk
Mar 27, 2014
Genomics in the Journals: Mar 27, 2014
Sep 17, 2013